PGT-A requires an embryo biopsy from the IVF laboratory. Using Bioarray’s new non-invasive PGT-A (niPGT-A) this analysis can be carried out using the culture media, in which the embryo delevops, as a sample. This avoids the need for a biopsy, with its advantages.

niPGT-A uses the DNA released by the embryo into the media during its development, especially after day 4. This is due to various physiological mechanisms such as apoptosis and cellular necrosis. Using this simple procedure, the IVF laboratory collects the culture media before embryo vitrification on day 6 (blastocyst) and sends it to Bioarray for analysis. The results, which are available after 15 days, indicate which embryos should be prioritized for transfer.

Advantages:

- Less demanding with regards to materials (laser, pipettes, media, etc) and handling

- No (potentially) damaging intervention is needed from the embryo

- The sample is representative of the ICM, not only the trophectoderm

Download Brochure

niPGT-A User Meeting

Amsterdam, 7 July

Click on the pictures to watch the presentations of the experts.

Welcome to the first edition of niPGT-A in Amsterdam

niPGT-A - Lab Workflow

niPGT-A - Clinical Management

CONTACT US